Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study Dr Riya Dave25 April 2025 8:30 PM ISTResearchers have identified in a new study that high levels of circulating sex hormones have a greater risk of endometrial cancer (EC) in...
Akums Drugs and Pharmaceuticals Gets CDSCO Panel Nod To study Norethindrone, Estradiol, Relugolix FDC Dr. Divya Colin30 July 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Abbott gets CDSCO Panel Nod To study FDC Dydrogesterone plus Estradiol Dr. Divya Colin14 March 2024 6:00 PM ISTNew Delhi: The drug major Abbott has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol, Relugolix film-coated tablet Dr. Divya Colin12 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on FDC Relugolix plus Estradiol plus Norethindrone Acetate Tablets Dr. Divya Colin10 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data on Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Study shows exposure to household chemicals can lower odds of getting pregnant Roshni Dhar19 Dec 2023 5:45 AM ISTExposure to phthalates, a group of plasticizing and solvent chemicals found in many household products, was linked to a lower probability of getting...
CDSCO Panel Tells Abbott India to revise phase IV CT protocol of Dydrogesterone plus Estradiol Tablets Dr. Divya Colin24 Sept 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined the drug major Abbott...
Akums Pharma Gets CDSCO Panel Nod To Manufacture, Market Estradiol, Progesterone FDC soft gelatin capsule Dr. Divya Colin16 Sept 2023 6:00 PM ISTNew Delhi: Granting for Phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer, Myovant Sciences get USFDA nod for MYFEMBREE Ruchika Sharma7 Aug 2022 11:30 AM ISTMYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a...
Abbott gets CDSCO panel nod for importing, marketing of Estradiol, Dydrogesterone FDC Medical Dialogues Team11 July 2021 10:30 AM ISTNew Delhi: Approving Phase III Clinical Trial (CT) waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Relugolix combo significantly reduces menstrual bleeding in uterine fibroids patients: NEJM Medha Baranwal18 Feb 2021 7:01 PM ISTUSA: Once-daily treatment with relugolix combination therapy (relugolix, estradiol and norethindrone acetate) significantly reduces menstrual bleeding...
